Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

37.5%

3 terminated/withdrawn out of 8 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 3

2(28.6%)

Phase 1

1(14.3%)

Early Phase 1

1(14.3%)

7Total

N/A(3)

Phase 3(2)

Phase 1(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04079764Completed

Surveillance of Complex Renal Cysts - the SOCRATIC Pilot Study

Role: collaborator

NCT02512887Not ApplicableUnknown

Caudal vs Local Anesthesia in Hypospadias

Role: collaborator

NCT03266900Early Phase 1Terminated

A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival

Role: collaborator

NCT03614611Not ApplicableTerminated

Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence

Role: collaborator

NCT02044965Phase 1Unknown

Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder

Role: collaborator

NCT04286152Phase 3Unknown

Mirabegron And Ureteral Stent-related Pain (MAP) Trial

Role: collaborator

NCT01915004Not ApplicableCompleted

The Effectiveness of a Bladder Training Video for Management of Lower Urinary Tract Symptoms.

Role: collaborator

NCT00752375Phase 3Withdrawn

Antibiotic Prophylaxis in Children With Pyelonephritis

Role: collaborator

All 8 trials loaded